Once-Weekly HIV Pill Matches Daily Treatment in Landmark Phase III Trials Ahead of AIDS 2026
By Michael Gwarisa A once-weekly pill for HIV treatment has performed as well as standard daily therapy in two landmark Phase III clinical trials, bringing researchers a step closer to offering people living with HIV the world’s first complete once-weekly oral treatment regimen. The findings from the ISLEND-1 and ISLEND-2 studies will be presented at
Read MoreMedia Must Lead the Charge in Ending HIV Stigma, Says Health Minister
By Michael Gwarisa As Zimbabwe grapples with persistently high levels of stigma against people living with HIV (PLHIV), the media has been called upon to champion responsible, inclusive, and stigma-free reporting to support national HIV response efforts. Despite international targets urging countries to reduce HIV-related stigma to below 5% by 2025, Zimbabwe’s HIV Stigma Index
Read More
Parliament Petitioned Over ARV Shortages
PEOPLE Living With HIV (PLHIV) have handed over a petition to the Parliament of Zimbabwe in a bid to push government to urgently allocate financial resources to arrest the prevailing drug shortage before the situation goes out of hand. By Michael Gwarisa The development comes at the back of indications that the National Aids Council
Read More